has function has role vaccinated in route immunizes against disease immunizes recipient ovarian cancer Homo sapiens therapeutic vaccine function vaccine in clinical trial role oral route ovarian cancer vaccine therapeutic cancer vaccine oral cancer vaccine V3-OVA NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C159540 cancer vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6354 NCT: https://clinicaltrials.gov/study/NCT03556566 6354 Jie Zheng A cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. The ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells. Ovarian cancer patients can be given one pill a day for three months. Hayleigh Kahn